- In October 2023, Precision Neuroscience Corporation expanded its operations by acquiring a manufacturing facility in Dallas. This facility will focus on producing key components for the company’s brain implants. The move is part of Precision Neuroscience's strategy to strengthen its manufacturing capabilities and support the growing demand for its advanced neural implant technologies
- In August 2023, Neuralink, a leading brain implant company, secured USD 280 million in funding to advance its U.S. FDA-approved technology. The investment will support the company’s efforts to further develop its neural implant solutions. Additionally, Neuralink plans to initiate human clinical trials in the near future, marking a significant step toward expanding its product's clinical applications
- In July 2021, Paradromics Inc. secured USD 20 million in funding from Prime Movers Lab and Westcott Investment Group. The company intends to leverage this investment to integrate neural science with medical device engineering. The funding will support Paradromics' efforts to develop innovative clinical therapies, advancing the potential of neural implants in treating various neurological conditions
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (F&B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), and Vagus Nerve Stimulation (VNS)), Application (Snapshot & Growth Engine, Chronic Pain, Parkinson's Disease, Epilepsy, and Others), End-User (Hospitals, Specialized Neurological Centers, and Outpatient Surgery Centers) – Industry Trends and Forecast to 2032
.
The Global Neural Implants Market size was valued at USD 2.37 USD Billion in 2024.
The Global Neural Implants Market is projected to grow at a CAGR of 12.65% during the forecast period of 2025 to 2032.
The major players operating in the market include NeuroPaceInc. , Boston Scientific Corporation , Fisher Wallace , SceneRay Co.Ltd , Beijing Pinchi Medical Equipment Co.Ltd , ALEVA NEUROTHERAPEUTICS , Medtronic , Abbott Stryker , Smith+Nephew , Integra LifeSciences Corporation Cochlear Ltd. , LivaNova PLC , Renishaw plc , MicroPort Scientific Corporation , NEVRO CORP , Inspire Medical SystemsInc. , AxonicsInc. , and Saluda Medical Pty Ltd. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
